Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1Gynecologic 1

Conditions

Neoplasms 1Lymphoma, Follicular 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Diet, Ketogenic × Clear all
NCT04750941 2025-03-04

Study of Copanlisib and Ketogenic Diet

Columbia University

Phase 2 Terminated
1 enrolled 9 charts
GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms

NCT01716468 2016-05-09

Ketogenic Diet in Advanced Cancer

VA Pittsburgh Healthcare System

Phase NA Completed
17 enrolled 5 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡